Annual Report and Accounts 2006 - Optos

Chairman’s Statement
Dr John M Padfield
“While our financial results and
key performance indicators are
important, they represent only
part of the story. The other part
is how we are differentiating
ourselves.”
2006 was a momentous year
for Optos plc. There were many
highlights. Perhaps most notable
was our successful flotation and
trading on the main market of the
London Stock Exchange in February
2006. Our public offering provided a
natural opportunity to reflect on the
substantial progress we have made
in introducing our revolutionary ultra
wide-field scanning laser technology
to the market and commercialising the
optomap® Retinal Exam in primary eye
and health care. It also enabled us to
look forward to new opportunities in
disease management in the secondary
and medical care market, and to
new geographies where we believe
that there is significant commercial
potential.
A strengthened balance sheet
provided us with the resources to
invest in growing the business and
the confidence to make a number
of commitments. At the time of our
initial public offering, we said that
we would deepen our penetration
in our existing markets, broaden
our product offering, enter into new
markets and maintain the highest
levels of customer satisfaction. With a
dedicated focus on delivering on our
plan and making strategic decisions
that will build for the future, we have
delivered on all of these fronts. Our
operational progress is firmly reflected
in our financial performance and I am
very pleased to report a strong set of
results for the financial year ended 30
September 2006.
Revenue was $67.7 million, up by 40%
over the previous year of $48.4 million.
Operating profit before share-based
payments increased by 46% to $6.5
million, up from $4.5 million last year.
Operating profit after share-based
payments increased by 32% from
Optos plc Annual Report & Accounts 2006